At 8.7% CAGR, Global Veterinary Molecular Diagnostics Market to...

At 8.7% CAGR, Global Veterinary Molecular Diagnostics Market to Surpass US$ 736.2 Mn By 2024, Forecast Report By Zion Market Research

Veröffentlicht vor 8 Monaten

972

Veterinary Molecular Diagnostics Market

The report covers forecast and analysis for the veterinary molecular diagnostics market on a global and regional level. The study provides historical data from 2017 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the veterinary molecular diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary molecular diagnostics market on a global level.

In order to give the users of this report a comprehensive view on the veterinary molecular diagnostics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment, technology segment, animal type segment, disease indication segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Get a Free Sample : https://www.zionmarketresearch.com/sample/veterinary-molecular-diagnostics-market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the veterinary molecular diagnostics market by segmenting the market based on technology veterinary molecular diagnostics market has been segmented into microarrays, polymerase chain reaction (PCR), and DNA sequencing. On the basis of the animal type, the market for veterinary molecular diagnostics is segmented into livestock animals and companion animals. Based on disease indication the veterinary molecular diagnostics market has been segmented into diarrhea pathogens detection, vector-borne diseases, respiratory pathogens detection, and others. Segmentation based on a product for veterinary molecular diagnostics includes kits & reagents, instruments & software, and services. The end-user segment for veterinary molecular diagnostics is divided into research institutes, clinical laboratories, and veterinary hospitals. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, Qatar, and South Africa. This segmentation includes demand for veterinary molecular diagnostics market based on technology, animal type, disease indication product, and end-user in all the regions and countries.

Directly Purchase a copy of the report with TOC @

https://www.zionmarketresearch.com/toc/veterinary-molecular-diagnostics-market

The report also includes detailed profiles of end players such as IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID.Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.

This report segments the global veterinary molecular diagnostics market as follows:

Global Veterinary Molecular Diagnostics Market: Product Segment Analysis